MedPath

UNACILYN

Brand Name: UNACILYN

Generic Name: AMPICILLIN (AS SODIUM) + SULBACTAM (AS SODIUM)

Active
Registration Number

DR-XY46453

Dosage Form

Sterile Powder For Injection

Issuance Date

December 1, 2023

Expiry Date

November 14, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength750 mg
Packaging10cc USP type III glass vials with 20mm grey bromo buytyl rubber stoppers and sealed in blue flip off seals

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
ANTIBACTERIALS (COMBINATIONS OF PENICILLINS, INCL. BETA-LACTAMASE INHIBITORS)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

AMPICILLIN (AS SODIUM)Active
Monograph: Ampicillin
SULBACTAM (AS SODIUM)Active

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform